Side-by-side comparison of AI visibility scores, market position, and capabilities
Vizgen is a Cambridge MA life sciences company commercializing MERSCOPE, a spatial genomics platform based on MERFISH technology licensed from Harvard; enables single-cell, subcellular-resolution RNA imaging in intact tissue;
Vizgen is a life sciences company founded in 2019 and headquartered in Cambridge, Massachusetts, that has commercialized the MERSCOPE platform — a spatial genomics instrument based on MERFISH (Multiplexed Error-Robust Fluorescence In Situ Hybridization) technology originally developed in the lab of Xiaowei Zhuang at Harvard University. MERSCOPE enables researchers to simultaneously measure the expression of hundreds to thousands of genes in individual cells while preserving the spatial location of those cells within intact tissue samples. This combination of single-cell resolution and spatial context is a significant advance over traditional bulk RNA sequencing (which loses spatial information) and earlier single-cell sequencing methods (which require tissue dissociation that destroys spatial architecture).
Saluda Medical is the pioneer of closed-loop spinal cord stimulation (SCS); FDA-approved Evoke SCS system with real-time neural feedback; raised $100M in Jan 2025; received FDA clearance for automated EVA programming platform.
Saluda Medical is a commercial-stage medical device company that has pioneered closed-loop neuromodulation therapy for chronic pain management. Headquartered in Macquarie Park, Australia (with US operations in Marlborough, Massachusetts), Saluda''s flagship product is the Evoke Spinal Cord Stimulation (SCS) System — the world''s first SCS system that senses and measures neural responses to stimulation (evoked compound action potentials, or ECAPs) and automatically adjusts therapy in real time based on each patient''s neurophysiological feedback. This closed-loop approach provides more precise, consistent pain relief compared to conventional open-loop SCS systems.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.